期刊文献+

当归四逆汤对雷诺病患者血小板5-羟色胺水平的影响 被引量:6

The Effect of Danggui Sini Decoction on Platelets 5-HT for the Patients Suffer from Raynaud's Disease
下载PDF
导出
摘要 目的观察当归四逆汤治疗雷诺病的临床效果及治疗前后患者5-羟色胺(5-HT)水平的改变情况。方法将符合雷诺氏病患者60例随机分成两组,试验组(n=30)内服当归四逆汤,对照组(n=30)口服硝苯地平缓释片,疗程均为4周。比较两组的临床疗效,同时检测试验组治疗前后患者血小板5-HT水平。结果试验组总有效率93.33%,对照组总有效率56.67%,两组比较差异有统计学意义(P<0.01)。试验组治疗前血小板5-HT水平(47.2±4.2)nmol/109血小板,试验组治疗后血小板5-HT水平(40.5±4.0)nmol/109血小板。试验组治疗前后血小板5-HT差异有统计学意义(P<0.05)。结论当归四逆汤治疗雷诺病疗效显著,明显优于硝苯地平。且先降低患者血小板5-HT水平。 Objective To explore the effect of danggui sini decoction on Platelets 5-HT for the patients suffer from Raynaud's disease. Methods Sixty patients of Raynaud's disease were randomly divided into group A(n = 30) and B( n = 30). Based on comprehensive treatment, the patients in group A were given danggui sini decoction, while those in group B were given nifedipine. After treatment 4 weeks, compare the clinical effect between group A and group B. Meanwhile, compare Platelets 5-HT in group A before treatment and four weeks after treatment. Results 4 weeks after treatment, the clinical efficient of group A is group B (P 〈 0. 01 ), and the core of 5-HT in group A is lower than treatment before (P 〈 0. 05 ). Conclusion Danggui sini decoction is more effective than nifedipine to cure the patients of Raynaud's disease. Meanwhile, danggui sini decoction decrease the core of Platelets 5-HT on the patients of Raynaud's disease.
作者 刘林峰
出处 《四川医学》 CAS 2016年第6期649-651,共3页 Sichuan Medical Journal
关键词 当归四逆汤 雷诺病 血小板 5-羟色胺 danggui sini decoction Raynaud's disease Platelets 5-HT
  • 相关文献

参考文献8

  • 1叶海东.当归四逆汤联合硝苯地平治疗雷诺病临床观察[J].新中医,2015,47(1):102-103. 被引量:8
  • 2Thompson AE, Pope JE. Calcium channel blockers for primary Raynaud's phenomenon:a meta-analysis[ J]. Rheumatology,2011,44 (2) :145-150.
  • 3王燕萍,沈明谦.当归四逆汤药理研究及临床应用新进展[J].兰州医学院学报,2004,30(3):98-99. 被引量:17
  • 4Watts SW, Davis RP. 5-hydroxtryptamine receptors in systemic hyper- tension : an arterial focus[ J]. Cardiovasc Ther,2011,29 ( 1 ) :54-67.
  • 5Watts SW. The love of a lifetime:5-HT in the cardiovascular system [J ]. Am J Physiol Regul Iutegr Comp Physiol, 2009, 296 (2 : 252-256.
  • 6Dawson P, Moffatt JD. Cardiovascular toxicity of novel psychoactive drugs:lessons from the past[ J]. Prog N europsychopharmacol Biol Psy- chiatry,2012,39(2) :244-252.
  • 7Coffman JD. Pathogenesis and treatment of Raynaud's phenomenon [ J ]. Cardiovascular drugs and therapy, 1990,4 (Suppl 1 ) :45-51.
  • 8Kaumann AJ, Levy FO. 5-Hydroxytryptamine receptors in the human cardiovascular system [ J ]. Pharmaeol Ther, 2006,111 ( 3 ) :674 -706.

二级参考文献16

共引文献23

同被引文献37

引证文献6

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部